NIH-funded research R21 grant

Creating a platform to study HIV and joint diseases in Uganda

Official title: Building a Collaborative Research and Training Platform for HIV and Rheumatic and Musculoskeletal Diseases in Uganda

Funded at Yale University · NIH-10998759 · Data updated 2026-11-12

This study is creating a helpful platform for people in Uganda who have both HIV and joint or muscle diseases, so we can better understand how these conditions affect each other and improve care for everyone living with them.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startAugust 19, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$174,753
NIH project number1R21TW012889-01
Project IDNIH-10998759 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who also suffer from rheumatic and musculoskeletal diseases.

Less likely to help

Patients without HIV or those who do not have rheumatic and musculoskeletal diseases may not benefit from this research.

What this research studies

This research aims to establish a collaborative platform that focuses on patients living with HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda. By creating a registry of these patients, the project will facilitate better understanding and management of the interactions between HIV and RMDs, which are increasingly prevalent in the region. The approach includes collecting epidemiological and clinical data to improve patient care and outcomes. This initiative addresses the growing challenge of non-communicable diseases among individuals with HIV, aiming to enhance healthcare strategies in resource-limited settings.

Why it matters

Potential benefit: If successful, this research could lead to improved management and treatment strategies for patients with HIV and RMDs, ultimately enhancing their quality of life.

How similar studies have gone: While the specific approach of this research is novel, there is growing evidence that addressing co-morbidities in HIV patients can lead to significant improvements in health outcomes.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Hsieh, Evelyn — Yale University
  • Study coordinator: Hsieh, Evelyn

Related research

Other NIH-funded projects on the same topics.

  • Longevity Metrics AI/ML Development Study

    Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.

    Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07808619

  • Urdu Translation and Validation of the Nordic Musculoskeletal Questionnaire

    This study tests an Urdu version of the E-NMQ to see if it reliably and accurately measures pain, stiffness, and weakness in adults with musculoskeletal conditions in Pakistan.

    Recruiting Riphah International University · Lahore, Punjab Province · NCT07626619

  • AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping

    This study tests whether intravenous AOC 1044 helps boys with Duchenne muscular dystrophy caused by mutations amenable to exon 44 skipping.

    Recruiting at 20 sites Phase 3 Avidity Biosciences, Inc. · Westmead, New South Wales and 19 other locations · NCT07587242

  • 100-Year Human Aging and Longevity Tracking Program

    This project will follow adults over their lifetimes to see if repeated health tests can predict lifespan, causes of death, serious disease, and loss of function.

    Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07563777

  • Shoulder Health After Rehab: Home-Based Strength Training for wheelchair users

    This study tests a home-based shoulder strength training program for manual wheelchair users who recently left rehabilitation to see if starting the training at 3 months versus 12 months after discharge affects shoulder health.

    Recruiting Swiss Paraplegic Research, Nottwil · Nottwil, Canton of Lucerne · NCT07245706

  • Dissolvable SakuraBead embolization for plantar fascia pain

    This trial will try dissolvable SakuraBead embolization in adults with plantar fasciitis to see if it reduces heel pain better than shockwave therapy.

    Recruiting CrannMed · Tashkent, Uzbekistan · NCT07241884

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.